title: Prostaglandin E1 for primary nonfunction following liver transplantation.
authors.affiliation: Liver Transplant Programme, University of Toronto, Ontario, Canada.
authors.forename: P D
authors.initials: PD
authors.lastname: Greig
authors.forename: G M
authors.initials: GM
authors.lastname: Woolf
authors.forename: M
authors.initials: M
authors.lastname: Abecassis
authors.forename: J
authors.initials: J
authors.lastname: Forster
authors.forename: S M
authors.initials: SM
authors.lastname: Strasberg
authors.forename: B R
authors.initials: BR
authors.lastname: Taylor
authors.forename: R A
authors.initials: RA
authors.lastname: Superina
authors.forename: M F
authors.initials: MF
authors.lastname: Glynn
authors.forename: M
authors.initials: M
authors.lastname: Ettles
authors.forename: L M
authors.initials: LM
authors.lastname: Blendis
mesh_terms: D000328:Adult; D000527:Alprostadil / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001780:Blood Coagulation Tests; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008099:Liver / Q000201:enzymology / Q000503:physiopathology; D008111:Liver Function Tests; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D001219:Aspartate Aminotransferases; D000527:Alprostadil